SIFCO Q3 FY26 net sales rise 18.1% to $26.1 million; continuing operations swings to breakeven loss
SIF•Q3 results and margin pressure
SIFCO posted a nominal loss from continuing operations on net sales of $26.1 million, up 18.1% year over year.
- Gross profit fell to $3.4 million from $5.9 million, pressured by a $3.2 million increase in LIFO expense.
- Cost of goods sold climbed to $22.7 million, rising 40.3% and reaching 86.9% of net sales.
- SG&A expenses increased to $3.1 million from $2.6 million, driven by $0.5 million in incentive compensation accruals.
- Backlog rose to $164.2 million at June 30, 2026 from $130.4 million a year earlier, with aerospace recovery cited as the main driver.
Related News
SHF Holdings Q2 revenue rises 4.8%, net loss widens on deemed dividend
SHFS•
Envoy Medical Q2 FY26 net loss attributable to common stockholders widens to $7.27 million; revenue falls 34.62% to $51,000
COCH•
